To test the effect of glycolysis inhibition on GVL preservation, lethally irradiated BALB/c recipients were engrafted with WT or Glut1T-KO T cells, TCDBM, accompanied by challenge with BCL1 cells, a BALB/c-derived leukemia/lymphoma cell line. The gene discussed is CCND1; the disease is leukemia.